Nuotio, Marja-Liisa http://orcid.org/0000-0002-6688-027X
Pervjakova, Natalia
Joensuu, Anni http://orcid.org/0000-0002-7547-7458
Karhunen, Ville http://orcid.org/0000-0001-6064-1588
Hiekkalinna, Tero
Milani, Lili http://orcid.org/0000-0002-5323-3102
Kettunen, Johannes http://orcid.org/0000-0002-3345-491X
Järvelin, Marjo-Riitta
Jousilahti, Pekka
Metspalu, Andres http://orcid.org/0000-0002-3718-796X
Salomaa, Veikko http://orcid.org/0000-0001-7563-5324
Kristiansson, Kati http://orcid.org/0000-0003-4688-107X
Perola, Markus
Article History
Received: 26 March 2019
Accepted: 9 November 2020
First Online: 25 November 2020
Competing interests
: J.K. reports owning stock options for Nightingale Health. V.S. has received honoraria from Novo Nordisk and Sanofi for consulting. He also has ongoing research collaboration with Bayer Ltd. (All unrelated to the present study). K.K. is a shareholder in companies DIAMYD MEDICAL AB, NEGEN OY, and TERVEYSTALO OYJ (less than 5% of shares). She worked part-time in NEGEN OY until January 2018. A.J. works part-time in NEGEN OY.